Insider · CIK 0001733883
David Lee Johnson
directorcooofficer
Files at CRBU (Caribou Biosciences, Inc.), VERA (Vera Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +40,500 | $0.00 | $0 | 40,500 | Feb 21, 2025 |
| Feb 18, 2025 | VERA Vera Therapeutics, Inc. | AGrant or award Class A Common Stock | +26,900 | $0.00 | $0 | 26,900 | Feb 20, 2025 |
| Feb 18, 2025 | VERA Vera Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +53,800 | $0.00 | $0 | 53,800 | Feb 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.